Marlowe Jennifer 4
4 · Solid Biosciences Inc. · Filed Dec 5, 2023
Insider Transaction Report
Form 4
Marlowe Jennifer
CSO, FA & Cardiac
Transactions
- Sale
Common Stock
2023-12-04$2.77/sh−4,890$13,525→ 6,998 total - Exercise/Conversion
Common Stock
2023-12-02+11,888→ 11,888 total - Exercise/Conversion
Restricted Stock Units
2023-12-02−11,888→ 35,667 total→ Common Stock (11,888 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs").
- [F2]This sale was made to cover withholding taxes following the vesting of the previously granted RSUs. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1).
- [F3]The RSUs were granted on December 2, 2022 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.